ImmunityBio: Despite Share Price & Funding Woes, Muddy Path To Long-Term Success

If you like what you have just read and want to receive at least 4 exclusive stock tips every week focused on Pharma, Biotech and Healthcare, then join me at my marketplace channel, Haggerston BioHealth . Invest alongside the model portfolio or simply access the investment bank-grade financial models and research. I hope to see you there.In my last note covering ImmunityBio (NASDAQ: IBRX ) in August, I provided a fairly detailed overview of the company, its entrepreneurial founder Dr Patrick Soon-Shiong – w ...